» Download Public Reports
About 4 500 reports
- Industry report
- May 2012
- 33 pages
- by Corporation
... Significant due to higher than anticipated placebo effect x in-105 shows clear efficacy as a prandial insulin in lowering post-prandial glucose levels in-105 india phase iii result summary financial ...
May 2012
... T see it as a major deterrent to the use of the medicine or the potential for tofacitinib to help patients in need of a different alternative to what's available today. With regard to the positioning ...
May 2012
... Medecins sans frontieres says. Cipla, which has been embroiled in a legal dispute with bayer over its right to produce nexavar, said cancer drugs were a small part of its business and the price cuts would ...
May 2012
... vaccine bundles from one manufactu in order to qualify for discounts. Similarly, some gpo contracts with member hospitals also require exclusivity The member cannot use a competing gpo and must ...
May 2012
... medicines, antibiotics, biochemical drugs and biological products (1) represents the premium / (discount) between offer price and closing price one day prior to pricing source: company announcements ...
» Purchase Premium Reports
(From $ 52 - $ 19 990)
About 4 100 reports
- $ 26 587
- Industry report
- May 2012
- by Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in global markets. The analyses provide essential market information ...
March 2012
$ 26 587
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for pasta in global markets. The analyses provide essential market information ...
May 2012
$ 15 016
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in European markets. The analyses provide essential market information ...
March 2012
$ 15 016
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for vaccines in European markets. The analyses provide essential market information ...
February 2012
$ 11 400
This market research report explores key issues in HIV across the US and five major EU industry s (France, Germany, Italy, Spain, and the UK). It contains an assessment of key HIV drugs, a discussion of ...
May 2012
$ 10 893
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in Asian markets. The analyses provide essential market information ...
March 2012
$ 10 893
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for vaccines in Asian markets. The analyses provide essential market information ...